Efficacy and Safety of Methoxyflurane Vaporized (PENTHROX) in the Treatment of Acute Trauma Pain in Pre-hospital Setting and in the Emergency Department in Italy: a Multicentre, Randomized, Controlled, Open-label Study

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Methoxyflurane (Primary) ; Ketoprofen; Morphine; Paracetamol
Indications Acute pain
Focus Therapeutic Use
Acronyms MEDITA
Sponsors Mundipharma Pharmaceuticals srl

Most Recent Events

15 Oct 2019 Results presented in a Mundipharma GmbH Media Release.
15 Oct 2019 According to a Mundipharma GmbH media release, data will be presented at the European Society for Emergency Medicine (EUSEM) Congress 2019.
12 Oct 2019 Results evaluating efficacy, practicality and safety of methoxyflurane versus standard analgesic treatment were published in the Advances in Therapy

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight